On July 22, COVID-19 antigen home self-test kit independently developed by Anhui Deepblue Medical Technology Co., Ltd. obtained the CE1434 certificate. This is after passing the British 3B stage test, the German BfarM special authorization, the Netherlands MINVWS special authorization, and the Czech home self-test certificate. Another major news that was another major innovation in DeepBlue’s anti-epidemic products. Anhui Deepblue Medical Technology Co., Ltd. is the first company in Anhui Province to obtain this certificate, and it is also one of the only ten companies in China.

Since the outbreak of Coronavirus (COVID-19) worldwide in 2020, Deepblue Medical has integrated a large number of technical research and development forces, and independently developed 5 types of new crowns including antibodies, antigens, antigen + antibody and antigen + influenza A&B detection kits, and neutralizing antibodies. Pneumonia detection kits have completed product registration and obtained registration certificates in more than 60 countries overseas. Among them, Deepblue Coronavirus (COVID-19) antigen home self-test kit was broadcast on German TV. Deepblue medical has developed rapidly in the global IVD industry with its superb product technology and high-quality product quality, making the "Made in China, Deepblue Manufacturing" reputation in the international market.

In the future, Deepblue Medical will continue to work hard to cooperate with all countries in the world with high-quality products, preferential prices, efficient production capacity, faster speed and better service.